These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 39227723)
41. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome. Chyrchel M; Rakowski T; Rzeszutko L; Legutko J; Dziewierz A; Dubiel JS; Dudek D Kardiol Pol; 2006 Dec; 64(12):1357-62; discussion 1363. PubMed ID: 17206539 [TBL] [Abstract][Full Text] [Related]
42. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2. Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T; Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012 [TBL] [Abstract][Full Text] [Related]
43. Serum total bilirubin levels and disease severity in patients with stable coronary artery disease. Yu J; Han JL; Wang GS; Guo LJ; Gao W Herz; 2017 Jun; 42(4):403-410. PubMed ID: 27714416 [TBL] [Abstract][Full Text] [Related]
44. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention. Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492 [TBL] [Abstract][Full Text] [Related]
45. Concomitant use of clopidogrel and statins and risk of major adverse cardiovascular events following coronary stent implantation. Schmidt M; Johansen MB; Maeng M; Kaltoft A; Jensen LO; Tilsted HH; Bøtker HE; Baron JA; Sørensen HT Br J Clin Pharmacol; 2012 Jul; 74(1):161-70. PubMed ID: 22243420 [TBL] [Abstract][Full Text] [Related]
46. Current statin usage for patients with acute coronary syndrome undergoing percutaneous coronary intervention: multicenter survey in Korea. Kim MJ; Jeon DS; Gwon HC; Kim SJ; Chang K; Kim HS; Tahk SJ; Clin Cardiol; 2012 Nov; 35(11):700-6. PubMed ID: 22825844 [TBL] [Abstract][Full Text] [Related]
47. Association of serum bilirubin with contrast-induced nephropathy and future cardiovascular events in patients undergoing coronary intervention. Huang SS; Huang PH; Wu TC; Chen JW; Lin SJ PLoS One; 2012; 7(8):e42594. PubMed ID: 22880046 [TBL] [Abstract][Full Text] [Related]
48. Higher serum total bilirubin predicts high risk of 3-year adverse outcomes in patients undergoing primary percutaneous coronary intervention. Gao F; Qiang H; Fan XJ; Xue Q; Bai L Ther Clin Risk Manag; 2019; 15():811-821. PubMed ID: 31308679 [No Abstract] [Full Text] [Related]
49. Statin therapy in patients with chronic kidney disease undergoing percutaneous coronary intervention (from the Evaluation of Drug Eluting Stents and Ischemic Events Registry). Dasari TW; Cohen DJ; Kleiman NS; Keyes MJ; Yen CH; Hanna EB; Saucedo JF Am J Cardiol; 2014 Feb; 113(4):621-5. PubMed ID: 24342762 [TBL] [Abstract][Full Text] [Related]
50. Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol. Lee SY; Oh SJ; Kim EJ; Oum CY; Park SH; Oh J; Kim JS; Kim BK; Park S; Chang HJ; Hong GR; Ko YG; Kang SM; Choi D; Ha JW; Hong MK; Jang Y; Chung N; Lee SH PLoS One; 2016; 11(11):e0166246. PubMed ID: 27824924 [TBL] [Abstract][Full Text] [Related]
51. Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38). Ojeifo O; Wiviott SD; Antman EM; Murphy SA; Udell JA; Bates ER; Mega JL; Sabatine MS; O'Donoghue ML JACC Cardiovasc Interv; 2013 Dec; 6(12):1275-81. PubMed ID: 24239201 [TBL] [Abstract][Full Text] [Related]
52. Comparison of Serum Uric Acid, Bilirubin, and C-Reactive Protein as Prognostic Biomarkers of In-Hospital MACE Between Women and Men With ST-Segment Elevation Myocardial Infarction. Baumann S; Huseynov A; Koepp J; Jabbour C; Behnes M; Becher T; Renker M; Lang S; Borggrefe M; Lehmann R; Akin I Angiology; 2016 Mar; 67(3):272-80. PubMed ID: 26032849 [TBL] [Abstract][Full Text] [Related]
53. Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis. Ebrahimi R; Saleh J; Toggart E; Shah AP; Azmoon S; Babaei H; Lee J; Smith R; Movahed MR; Rubin SA J Invasive Cardiol; 2008 Jun; 20(6):292-5. PubMed ID: 18523323 [TBL] [Abstract][Full Text] [Related]
54. High dose statin loading prior to percutaneous coronary intervention decreases cardiovascular events: a meta-analysis of randomized controlled trials. Benjo AM; El-Hayek GE; Messerli F; DiNicolantonio JJ; Hong MK; Aziz EF; Herzog E; Tamis-Holland JE Catheter Cardiovasc Interv; 2015 Jan; 85(1):53-60. PubMed ID: 24272891 [TBL] [Abstract][Full Text] [Related]
55. Serum apolipoprotein E levels predict residual cardiovascular risk in patients with chronic coronary syndrome undergoing first percutaneous coronary intervention and on-statin treatment. Fukase T; Dohi T; Chikata Y; Takahashi N; Endo H; Doi S; Nishiyama H; Kato Y; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Daida H; Minamino T Atherosclerosis; 2021 Sep; 333():9-15. PubMed ID: 34418683 [TBL] [Abstract][Full Text] [Related]
56. Levels of plasma Quaking and cyclooxygenase-2 predict in-stent restenosis in patients with coronary artery disease after percutaneous coronary intervention. Wang P; Kuang Y; Liu Y; Zhang Y; Gao H; Ma Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):739-747. PubMed ID: 35837773 [TBL] [Abstract][Full Text] [Related]
57. Prolonged CRP Increase After Percutaneous Coronary Intervention Is Associated with High Thrombin Concentrations and Low Platelet' Response to Clopidogrel in Patients with Stable Angina. Mostowik M; Siniarski A; Gołębiowska-Wiatrak R; Nessler J; Gajos G Adv Clin Exp Med; 2015; 24(6):979-85. PubMed ID: 26771969 [TBL] [Abstract][Full Text] [Related]
58. Impact of serum albumin levels on long-term outcomes in patients undergoing percutaneous coronary intervention. Wada H; Dohi T; Miyauchi K; Shitara J; Endo H; Doi S; Naito R; Konishi H; Tsuboi S; Ogita M; Kasai T; Okazaki S; Isoda K; Suwa S; Daida H Heart Vessels; 2017 Sep; 32(9):1085-1092. PubMed ID: 28429111 [TBL] [Abstract][Full Text] [Related]
59. Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy. Gibson CM; Pride YB; Hochberg CP; Sloan S; Sabatine MS; Cannon CP; J Am Coll Cardiol; 2009 Dec; 54(24):2290-5. PubMed ID: 19958964 [TBL] [Abstract][Full Text] [Related]